Expert insights. Personalized for you.
The German companies will work together to push a shot using similar technology as Moderna's and BioNTech's over the finish line MORE
Here's five key takeaways from this week's developments. Bio DevelopmentsItâs been a big week for mRNA-based COVID-19 vaccines: with both Pfizer/BioNTech and Moderna reporting impressive efficacy for their COVID-19 vaccine candidates. MORE
Defying expectations, BioNTech and Moderna each designed and developed highly effective coronavirus shots far faster than previously considered possible MORE
The post Developing Drug Products with the Label’s Commercial Value in Mind appeared first on Camargo. Whether you plan to out-license or commercialize your product, getting the label right matters. MORE
The post In the News: July Regulatory and Development Updates appeared first on Camargo. 505(b)(2) Development Blog DESI Drug Regulatory Strategy & SubmissionsEach month, Camargo’s “In the News” series will highlight important changes and advancements in the. MORE
The current pandemic highlights how remote healthcare robots currently being developed at SFU could be beneficial in the future Credit: Simon Fraser University Robots that could take on basic healthcare tasks to support the work of doctors and nurses may be the way of the future. MORE
Researchers at Chalmers University of Technology, Gothenburg, Sweden, have developed a novel type of thermometer that can simply and quickly measure temperatures during quantum calculations with extremely high accuracy. MORE
Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explore how those changes could impact your program. Fitbit developing algorithm COVID-19 early detection. MORE
Care needs to be taken during analytical development to ensure methodologies firstly, reflect the MoA, and are also reproducible, accurate, and robust MORE
The post Drug Development for an Aging Population appeared first on Camargo. Fueled by unprecedented medical, technological and social advancements of the past century, it should be. Blog Combination Products MORE
Vaccine development is an arduous process, taking about 10-15 years on average to accomplish. But with the imminent worries surrounding the COVID-19 pandemic putting unprecedented pressure on our healthcare systems and economies, unprecedented measures needed to be put in place MORE
The two Swiss firms will develop protein drugs that are meant to have similar effects as coronavirus antibodies, but would be easier to mass produce MORE
Get up to speed with the latest developments in COVID-19 vaccines here. Bio DevelopmentsTook a break over Christmas and New Year? MORE
ConserV Bioscience and eTheRNA immunotherapies are to collaborate on development of mRNA vaccines for infectious diseases. Bio Developments MORE
Novavax is expanding its Maryland campus to support the companyâs growth and the development of a COVID-19 vaccine. Bio Developments MORE
The post Multidisciplinary Team Advances Immuno-Oncology Development appeared first on Camargo. Blog Clinical Studies, Phases I-IV CMC Regulatory Strategy & Submissions Services MORE
130 It is designed to simulate reservoir conditions Credit: @SamaraPolytech The original facility developed at Samara Polytech will help to explore the earth’s interior. MORE
The post Multidisciplinary Team Advances Immuno-Oncology Development appeared first on Camargo. Case Studies MORE
130 
Camargo can help you to develop the right pricing and access strategy for your product; contact us for more information. The post In the News: November Regulatory and Development Updates appeared first on Camargo. Remote Document Review Leads to CRL: Be Careful What You Wish for? MORE
Technology and Engineering Biology Biomedical/Environmental/Chemical Engineering Climate Change Climate Science Environmental Health Pollution/Remediation Research/Development MORE
The post What to Expect from the FDA During COVID-19 Product Development appeared first on Camargo. As the COVID-19 national emergency stretches on in the United States, the eyes of the. Blog Regulatory Strategy & Submissions MORE
The post Patient-Centered Drug Development for Oncology Products appeared first on Camargo. Oncology patients face a difficult journey — a frightening diagnosis followed by intricate and oftentimes. MORE
Safety studies in animals are an integral piece of the development and eventual approval of news drugs, as they are required by all regulatory agencies around the world. The post Navigating the Global NHP Shortage: How to Keep Your Development Program on Track appeared first on Camargo. MORE
Russian researchers have developed an inexpensive, safe, and reliable packed eggs surface disinfection technology. It allows to kill bacteria and to raise healthy chickens with less dose of antibiotics Credit: UrFU / Ilya Safarov. MORE
Similarly, in rare disease drug development, where a placebo control group may not be an option, a single-arm trial can be a successful approach. Natural history data becomes critical for product development when there is no concurrent control. MORE
have entered into a research collaboration and license agreement to develop immunocytokines. Bio DevelopmentsAjinomoto Co., Inc, and Bright Peak Therapeutics Inc. MORE
Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. The post In the News: September Regulatory and Development Updates appeared first on Camargo. MORE
Researchers develop a low-cost and fast method to detect a COVID-19 infection from a pool of gargle lavage samples Credit: MPI f. MORE
Journal of Instrumentation Researchers from MIPT have developed a prototype detector of solar particles. Technology and Engineering Electromagnetics Research/Development Space/Planetary Science Stars/The SunCredit: Egor Stadnichuk et al./Journal MORE
Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. The post In the News: October Regulatory and Development Updates appeared first on Camargo. MORE
Bio DevelopmentsMerck is shutting down the programs linked to its two COVID-19 vaccine candidates following early trial data indicating that they failed to generate immune responses comparable to a natural infection or existing vaccines. MORE
Independent reviewers found the benefits of the lung disease drug didn't outweigh its risks, marking a second major setback in six months for the companies' partnership MORE
Technology and Engineering Algorithms/Models Calculations/Problem-Solving Computer Science Mathematics/Statistics Research/Development Robotry/Artificial Intelligence Software Engineering Technology/Engineering/Computer Science Theory/Design MORE
Despite this promising finding, the authors warn that treatment rates in developing countries are still very low. Chemistry AND Physics Developing Countries Disease in the Developing World Earth Science Energy Sources Geography Hydrology/Water Resources MORE
The Mitochondria-Targeted Drug Development Digital Summit (April 27-29) is the only industry-led meeting focused on end-to-end mitochondria-targeting. Larimar Therapeutics examining CTI-1601 as a potential protein replacement therapy under development for Friedreich’s Ataxia. MORE
Given all the uncertainties of fill and finish in clinical development, one thing is certain – there is little room for failure, and rarely a second chance MORE
The British drugmaker will pay the San Francisco-based biotech $225 million upfront, while also investing another $120 million in Vir shares MORE
Technology and Engineering Chemistry/Physics/Materials Sciences Diet/Body Weight Food/Food Science Grants/Funding Medicine/Health Nanotechnology/Micromachines Nutrition/Nutrients Public Health Research/Development Technology/Engineering/Computer Science MORE
Gritstone Oncology, known for its cancer research, is drawing attention in infectious disease, signing a deal with Gilead two weeks after announcing plans to develop a coronavirus vaccine MORE
Axon Neuroscience is launching the world's first crowdfunding exercise for the development of a COVID-19 vaccine, following what it says are strong pre-clinical results for its candidate. MORE
Delaying less developed countries’ efforts to reduce carbon emissions would have a minimal impact on global temperature change That is the key finding in a new study published today in Environmental Research Letters by scientists from the Carnegie Institution for Science, USA and the University of Waterloo, Canada. Atmospheric Science Climate Change Climate Science Developing Countries Earth Science Poverty/Wealth MORE
Seekyo, a startup biotechnology company specializing in the development of âsmart chemotherapyâ drugs that limit harmful side effects, has raised in excess of â650,000 (US$775K) in bridge funding. Bio Developments MORE
The drugmaker, one of the largest vaccine developers globally, won't move forward with either of two candidates it's been testing after disappointing data in early trials MORE
But it does suggest reduced protection against the South Africa strain, and so the company is also developing a new booster designed for maximum efficacy against this variant. Bio Developments MORE
Development Related Topics 
Bio Pharma Dive
JANUARY 25, 2021
The drugmaker, one of the largest vaccine developers globally, won't move forward with either of two candidates it's been testing after disappointing data in early trials
Camargo
AUGUST 13, 2020
The post In the News: July Regulatory and Development Updates appeared first on Camargo. 505(b)(2) Development Blog DESI Drug Regulatory Strategy & SubmissionsEach month, Camargo’s “In the News” series will highlight important changes and advancements in the.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
DECEMBER 9, 2020
Defying expectations, BioNTech and Moderna each designed and developed highly effective coronavirus shots far faster than previously considered possible
Camargo
SEPTEMBER 15, 2020
Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explore how those changes could impact your program. Fitbit developing algorithm COVID-19 early detection.
Bio Pharma Dive
FEBRUARY 1, 2021
Gritstone Oncology, known for its cancer research, is drawing attention in infectious disease, signing a deal with Gilead two weeks after announcing plans to develop a coronavirus vaccine
Camargo
JULY 24, 2020
The post Multidisciplinary Team Advances Immuno-Oncology Development appeared first on Camargo. Case Studies
Bio Pharma Dive
FEBRUARY 22, 2021
Care needs to be taken during analytical development to ensure methodologies firstly, reflect the MoA, and are also reproducible, accurate, and robust
Camargo
MAY 19, 2020
The post What to Expect from the FDA During COVID-19 Product Development appeared first on Camargo. As the COVID-19 national emergency stretches on in the United States, the eyes of the. Blog Regulatory Strategy & Submissions
Camargo
JUNE 3, 2020
The post Patient-Centered Drug Development for Oncology Products appeared first on Camargo. Oncology patients face a difficult journey — a frightening diagnosis followed by intricate and oftentimes.
Bio Pharma Dive
OCTOBER 28, 2020
The two Swiss firms will develop protein drugs that are meant to have similar effects as coronavirus antibodies, but would be easier to mass produce
Scienmag
MARCH 5, 2021
Researchers develop a low-cost and fast method to detect a COVID-19 infection from a pool of gargle lavage samples Credit: MPI f.
Scienmag
APRIL 13, 2021
Technology and Engineering Chemistry/Physics/Materials Sciences Diet/Body Weight Food/Food Science Grants/Funding Medicine/Health Nanotechnology/Micromachines Nutrition/Nutrients Public Health Research/Development Technology/Engineering/Computer Science
Camargo
NOVEMBER 11, 2020
Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. The post In the News: October Regulatory and Development Updates appeared first on Camargo.
BioPharma Reporter
JANUARY 4, 2021
Get up to speed with the latest developments in COVID-19 vaccines here. Bio DevelopmentsTook a break over Christmas and New Year?
Camargo
DECEMBER 9, 2020
Camargo can help you to develop the right pricing and access strategy for your product; contact us for more information. The post In the News: November Regulatory and Development Updates appeared first on Camargo. Remote Document Review Leads to CRL: Be Careful What You Wish for?
BioPharma Reporter
MARCH 8, 2021
ConserV Bioscience and eTheRNA immunotherapies are to collaborate on development of mRNA vaccines for infectious diseases. Bio Developments
Camargo
OCTOBER 14, 2020
Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. The post In the News: September Regulatory and Development Updates appeared first on Camargo.
Bio Pharma Dive
FEBRUARY 1, 2021
Given all the uncertainties of fill and finish in clinical development, one thing is certain – there is little room for failure, and rarely a second chance
Bio Pharma Dive
JANUARY 7, 2021
The German companies will work together to push a shot using similar technology as Moderna's and BioNTech's over the finish line
Scienmag
MARCH 9, 2021
Technology and Engineering Biology Biomedical/Environmental/Chemical Engineering Climate Change Climate Science Environmental Health Pollution/Remediation Research/Development
Scienmag
DECEMBER 15, 2020
Delaying less developed countries’ efforts to reduce carbon emissions would have a minimal impact on global temperature change That is the key finding in a new study published today in Environmental Research Letters by scientists from the Carnegie Institution for Science, USA and the University of Waterloo, Canada. Atmospheric Science Climate Change Climate Science Developing Countries Earth Science Poverty/Wealth
Bio Pharma Dive
FEBRUARY 17, 2021
The British drugmaker will pay the San Francisco-based biotech $225 million upfront, while also investing another $120 million in Vir shares
Bio Pharma Dive
FEBRUARY 11, 2021
Independent reviewers found the benefits of the lung disease drug didn't outweigh its risks, marking a second major setback in six months for the companies' partnership
Camargo
DECEMBER 31, 2019
The post Drug Development for an Aging Population appeared first on Camargo. Fueled by unprecedented medical, technological and social advancements of the past century, it should be. Blog Combination Products
BioPharma Reporter
JANUARY 25, 2021
But it does suggest reduced protection against the South Africa strain, and so the company is also developing a new booster designed for maximum efficacy against this variant. Bio Developments
Scienmag
FEBRUARY 26, 2021
The current pandemic highlights how remote healthcare robots currently being developed at SFU could be beneficial in the future Credit: Simon Fraser University Robots that could take on basic healthcare tasks to support the work of doctors and nurses may be the way of the future.
BioPharma Reporter
MARCH 18, 2021
Seekyo, a startup biotechnology company specializing in the development of âsmart chemotherapyâ drugs that limit harmful side effects, has raised in excess of â650,000 (US$775K) in bridge funding. Bio Developments
Camargo
AUGUST 5, 2020
The post Developing Drug Products with the Label’s Commercial Value in Mind appeared first on Camargo. Whether you plan to out-license or commercialize your product, getting the label right matters.
Scienmag
MARCH 10, 2021
Technology and Engineering Algorithms/Models Calculations/Problem-Solving Computer Science Mathematics/Statistics Research/Development Robotry/Artificial Intelligence Software Engineering Technology/Engineering/Computer Science Theory/Design
Scienmag
APRIL 2, 2021
Russian researchers have developed an inexpensive, safe, and reliable packed eggs surface disinfection technology. It allows to kill bacteria and to raise healthy chickens with less dose of antibiotics Credit: UrFU / Ilya Safarov.
Scienmag
FEBRUARY 18, 2021
It is designed to simulate reservoir conditions Credit: @SamaraPolytech The original facility developed at Samara Polytech will help to explore the earth’s interior.
BioPharma Reporter
JANUARY 25, 2021
Bio DevelopmentsMerck is shutting down the programs linked to its two COVID-19 vaccine candidates following early trial data indicating that they failed to generate immune responses comparable to a natural infection or existing vaccines.
Scienmag
MARCH 22, 2021
Researchers at Chalmers University of Technology, Gothenburg, Sweden, have developed a novel type of thermometer that can simply and quickly measure temperatures during quantum calculations with extremely high accuracy.
Scienmag
FEBRUARY 8, 2021
Despite this promising finding, the authors warn that treatment rates in developing countries are still very low. Chemistry AND Physics Developing Countries Disease in the Developing World Earth Science Energy Sources Geography Hydrology/Water Resources
BioSpace
DECEMBER 2, 2020
Vaccine development is an arduous process, taking about 10-15 years on average to accomplish. But with the imminent worries surrounding the COVID-19 pandemic putting unprecedented pressure on our healthcare systems and economies, unprecedented measures needed to be put in place
Scienmag
OCTOBER 13, 2020
Journal of Instrumentation Researchers from MIPT have developed a prototype detector of solar particles. Technology and Engineering Electromagnetics Research/Development Space/Planetary Science Stars/The SunCredit: Egor Stadnichuk et al./Journal
BioPharma Reporter
NOVEMBER 3, 2020
Novavax is expanding its Maryland campus to support the companyâs growth and the development of a COVID-19 vaccine. Bio Developments
Camargo
OCTOBER 15, 2020
Similarly, in rare disease drug development, where a placebo control group may not be an option, a single-arm trial can be a successful approach. Natural history data becomes critical for product development when there is no concurrent control.
BioPharma Reporter
SEPTEMBER 28, 2020
Axon Neuroscience is launching the world's first crowdfunding exercise for the development of a COVID-19 vaccine, following what it says are strong pre-clinical results for its candidate.
BioPharma Reporter
APRIL 1, 2021
have entered into a research collaboration and license agreement to develop immunocytokines. Bio DevelopmentsAjinomoto Co., Inc, and Bright Peak Therapeutics Inc.
Pharma Phorum
JANUARY 25, 2021
The Mitochondria-Targeted Drug Development Digital Summit (April 27-29) is the only industry-led meeting focused on end-to-end mitochondria-targeting. Larimar Therapeutics examining CTI-1601 as a potential protein replacement therapy under development for Friedreich’s Ataxia.
Camargo
JANUARY 12, 2021
Safety studies in animals are an integral piece of the development and eventual approval of news drugs, as they are required by all regulatory agencies around the world. The post Navigating the Global NHP Shortage: How to Keep Your Development Program on Track appeared first on Camargo.
BioPharma Reporter
NOVEMBER 19, 2020
Here's five key takeaways from this week's developments. Bio DevelopmentsItâs been a big week for mRNA-based COVID-19 vaccines: with both Pfizer/BioNTech and Moderna reporting impressive efficacy for their COVID-19 vaccine candidates.
Let's personalize your content